5.0
Jan 14, 2021
Current employee, less than 1 year
London, England
Recommend
CEO approval
Business outlook
Pros
- Good AI device developed by good science and clinical rigour - Motivated and supporting team with a "can-do" approach - Lots of potential to expand over the next year
Cons
- As any startup in its growth period, lots to do! which is not necessarily a bad thing